Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

591 ARTÍCULOS , VIENDO DEL 361 AL 375

[Research progress and clinical application potential of silicon-based microring resonators in biomedical detection]

Wang Y, Zhao F.

Sheng Wu Gong Cheng Xue Bao. 2025 Apr 25;41(4):1309-1322. doi: 10.13345/j.cjb.240702.

Dysregulation of the molecular clock by blood-borne factors in Alzheimer's disease patients

Zhao C, Li T, Hao S, Zhao L, Han Y, Cai Y.

J Neurol. 2025 Jan 15;272(2):121. doi: 10.1007/s00415-024-12824-0.

Proper Name Recall as an Early Indicator of Preclinical Alzheimer Disease Pathology

Mueller KD, Soldan A, Langhough R, Bruno D, Jauregi-Zinkunegi A, Basche K, Hale MR, He D, Moghekar A, Hermann B, Albert M, Pettigrew C.

Alzheimer Dis Assoc Disord. 2025 Oct-Dec 01;39(4):269-276. doi: 10.1097/WAD.0000000000000695. Epub 2025 Nov 10.

The potential role of machine learning and deep learning in differential diagnosis of Alzheimer's disease and FTD using imaging biomarkers: A review

Mirabian S, Mohammadian F, Ganji Z, Zare H, Hasanpour Khalesi E.

Neuroradiol J. 2025 Oct;38(5):571-587. doi: 10.1177/19714009251313511. Epub 2025 Jan 9.

Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review

Porta-Mas C, Grau-Rivera O, Gispert JD, Blasco GS, Sánchez-Benavides G.

Alzheimers Dement. 2025 Dec;21(12):e70753. doi: 10.1002/alz.70753.

Measurement Error and Methodologic Issues in Analyses of the Proportion of Variance Explained in Cognition

Nichols E, Aslanyan V, Adrien TV, Andrews RM, Fardo DW, Gavett BE, Paterson TSE, Turney IC, Young CB, Uanhoro JO, Gross AL, Initiative FTADN.

Neuropsychol Rev. 2025 Dec;35(4):731-744. doi: 10.1007/s11065-024-09655-1. Epub 2024 Nov 20.

[Advances in measurements and standardization of plasma phosphorylated tau217 as a biomarker for Alzheimer's disease]

Liu HY, Lin YL.

Zhonghua Yu Fang Yi Xue Za Zhi. 2025 Dec 6;59(12):2209-2215. doi: 10.3760/cma.j.cn112150-20250331-00265.

Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer's Disease in Blood

Wang J, Lu X, He Y.

Biosensors (Basel). 2025 Feb 4;15(2):85. doi: 10.3390/bios15020085.

Early axonal degeneration linked to clinical decline in Alzheimer's disease progression revealed with diffusion MRI

Gong Z, Laporte JP, Guo AY, Bilgel M, Bae J, Fox NY, de Rouen A, Zhang N, Taranath A, de Cabo R, Egan JM, Ferrucci L, Bouhrara M; Alzheimer’s Disease Neuroimaging Initiative.

J Clin Invest. 2025 Nov 27;136(3):e196638. doi: 10.1172/JCI196638. eCollection 2026 Feb 2.

Antiamyloid Therapy and Cerebral Blood Flow Changes on MRI: A Potential Longitudinal Biomarker of Treatment Response?

Ricaurte-Fajardo A, Ivanidze J, Zhang D, Mahmud M, Yasen W, Ravdin L, Pahlajani S, Leon M, Nordvig AS, Chiang GC.

AJNR Am J Neuroradiol. 2025 Jul 1;46(7):1439-1445. doi: 10.3174/ajnr.A8654.

The Eye as a Window to Brain Health: Can Retinal Imaging and AI Modeling Predict Alzheimer's Disease?

Awodiya E.

Brain Behav. 2025 Oct;15(10):e70890. doi: 10.1002/brb3.70890.

Traumatic Brain Injury and Alzheimer's Disease Biomarkers: A Systematic Review of Findings from Amyloid and Tau Positron Emission Tomography

Dybing KM, Vetter CJ, Dempsey DA, Chaudhuri S, Saykin AJ, Risacher SL.

J Neurotrauma. 2025 Mar;42(5-6):333-348. doi: 10.1089/neu.2024.0055. Epub 2024 Dec 6.

Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins

Niwa M, Noda K, Kobayashi Y, Kageyama I, Kodama K.

Bioanalysis. 2025 May;17(10):671-680. doi: 10.1080/17576180.2025.2515011. Epub 2025 Jun 4.

A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathology

Liou JJ, Lou J, Flores-Aguilar L, Nakagiri J, Yong W, Hom CL, Doran EW, Totoiu MO, Lott I, Mapstone M, Keator DB, Brickman AM, Wright ST, Nelson B, Lai F, Xicota L, Dang LT, Li J, Santini T, Mettenburg JM, Ikonomovic MD, Kofler J, Ibrahim T, Head E; Alzheimer Biomarker Consortium ‐ Down Syndrome.

Alzheimers Dement. 2025 Feb;21(2):e14479. doi: 10.1002/alz.14479. Epub 2025 Jan 27.

Mesenchymal Stem Cell-Derived Extracellular Vesicles in Alzheimer's Disease: A Novel Cell-Free Therapeutic Strategy and Diagnostic Biomarker

Wang X, Yang F, Chen P, Yang M, Deng Y, Zhan Z.

Int J Nanomedicine. 2025 Dec 3;20:14375-14391. doi: 10.2147/IJN.S556625. eCollection 2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias